IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 186 filers reported holding IMMUNOGEN INC in Q1 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $437,000 | +41.9% | 85,660 | -32.7% | 0.02% | +66.7% |
| Q3 2019 | $308,000 | -35.0% | 127,305 | +154.6% | 0.02% | +7.1% |
| Q3 2018 | $474,000 | -90.7% | 50,006 | -90.5% | 0.01% | -91.1% |
| Q2 2018 | $5,124,000 | -3.3% | 526,660 | +4.5% | 0.16% | -7.1% |
| Q1 2018 | $5,300,000 | +69.1% | 503,765 | +3.0% | 0.17% | +76.0% |
| Q4 2017 | $3,135,000 | -16.5% | 489,035 | -0.3% | 0.10% | -19.3% |
| Q3 2017 | $3,753,000 | +141.8% | 490,635 | +124.7% | 0.12% | +183.3% |
| Q2 2017 | $1,552,000 | – | 218,320 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |